A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Recruiting · NCT07527910 · Registry updated 2026-09-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Recruiting | Phase 2 | 2026-09-29 | NCT07527910 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Regeneron Pharmaceuticals | 238 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Advanced Medical Trials | Georgetown | United States | 2 |
| American Research Corporation | Austin | United States | 4 |
| American Research Corporation at The Texas Liver Institute | San Antonio | United States | 10 |
| Arizona Liver Health - Tucson | Tucson | United States | 8 |
| California Liver Research Institute | Pasadena | United States | 10 |
| Evolution Clinical Trials | Miami | United States | 4 |
| Health Awareness, Inc | Jupiter | United States | 2 |
| Southern California Research Center | Coronado | United States | 17 |
| Tandem Clinical Research, Plaza II | Metairie | United States | 1 |